Copyright © 2002 by the European Society of Cardiology.
Editorials
A partial CURE for acute coronary syndromesbut how did it happen?
Department of Clinical Pharmacology, Royal College of Surgeons in Ireland, Dublin, Ireland
References
- The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators, Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation, N Engl J Med, 2001, 345, 494, 502
- Eikelboom, JW, Weitz, JI, Budaj, A, Clopidogrel does not suppress blood markers of coagulation activation in aspirin-treated patients with non-ST-elevation acute coronary syndromes, Eur Heart J, 2002, 23, 1771, 9
- Boldt, J, Osmer, C, Linke, LC, Gorlach, G, Hempelmann, G, Hypothermic versus normothermic cardiopulmonary bypass: influence on circulating adhesion molecules, J Cardiothorac Vasc Anesth, 1996, 10, 342, 7
- Kamath, S, Blann, AD, Caine, GJ, Gurney, D, Chin, BS, Lip, GY, Platelet P-selectin levels in relation to plasma soluble P-selectin and beta-thromboglobulin levels in atrial fibrillation, Stroke, 2002, 33, 1237, 42
- Dempfle, CE, Kontny, F, Abildgaard, U, Predictive value of coagulation markers concerning clinical outcome 90 days after anterior myocardial infarction, Thromb Haemost, 1999, 81, 701, 4
- Szczeklik, A, Krzanowski, M, Gora, P, Radwan, J, Antiplatelet drugs and generation of thrombin in clotting blood, Blood, 1992, 80, 2006, 11
- Topol, EJ, Quinn, MJ, Common variations in platelet glycoproteins: pharmacogenomic implications, Pharmacogenomics, 2001, 2, 341, 52
- Hojo, Y, Ikeda, U, Katsuki, T, Mizuno, O, Shimada, K, Increased expression of hemostasis markers in the coronary circulation in patients with coronary artery disease, Am Heart J, 2000, 139, 561, 2
- Fitzgerald, DJ, Roy, L, Catella, F, FitzGerald, GA, Platelet activation in unstable coronary disease, N Engl J Med, 1986, 315, 983, 9
- Cannon, CP, McCabe, CH, Wilcox, RG, Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial, Circulation, 2000, 102, 149, 56
- Eriksson, BI, Bauer, KA, Lassen, MR, Turpie, AG, Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery, N Engl J Med, 2001, 345, 1298, 304
- Dyke, CK, Becker, RC, Kleiman, NS, First experience with direct factor Xa inhibition in patients with stable coronary disease: a pharmacokinetic and pharmacodynamic evaluation, Circulation, 2002, 105, 2385, 91
- O'Connor, FF, Shields, DC, Fitzgerald, A, Cannon, CP, Braunwald, E, Fitzgerald, DJ, Genetic variation in glycoprotein IIb/IIIa (GPIIb/IIIa) as a determinant of the responses to an oral GPIIb/IIIa antagonist in patients with unstable coronary syndromes, Blood, 2001, 98, 3256, 60
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||